IVRN (Innoveren Scientific) Current Ratio: 0.08 (As of Sep. 2023)


IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Current Ratio?

Innoveren Scientific IVRN 16 Current Ratio is 0.08 as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Innoveren Scientific's current ratio for the quarter that ended in Sep. 2023 was 0.08.

Innoveren Scientific has a current ratio of 0.08. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Innoveren Scientific has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Innoveren Scientific's Current Ratio or its related term are showing as below:

IVRN's Current Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.885
* Ranked among companies with meaningful Current Ratio only.

Innoveren Scientific  (OTCPK:IVRN) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Innoveren Scientific Current Ratio Related Terms


Innoveren Scientific Current Ratio Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Current Ratio Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.39 0.61 0.04 0.01

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.01 0.03 0.02 0.08

IVRN vs GNCA, ISCO, FNAM: Current Ratio Comparison

For the Biotechnology subindustry, Innoveren Scientific's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific Current Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Current Ratio distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Current Ratio falls into.


IVRN
16GF Score
Innoveren Scientific Inc IVRN
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Innoveren Scientific's Current Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Current Ratio (A: Dec. 2022 )=Total Current Assets (A: Dec. 2022 )/Total Current Liabilities (A: Dec. 2022 )
=0.084/7.477
=0.01

Innoveren Scientific's Current Ratio for the quarter that ended in Sep. 2023 is calculated as

Current Ratio (Q: Sep. 2023 )=Total Current Assets (Q: Sep. 2023 )/Total Current Liabilities (Q: Sep. 2023 )
=0.749/9.661
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.08 mean?
Innoveren Scientific (IVRN) has a Current Ratio of 0.08 as of Sep. 2023.
Is Innoveren Scientific's Current Ratio too high?
Innoveren Scientific's current Current Ratio is 0.08. The Biotechnology industry median Current Ratio is 3.89. Innoveren Scientific's value of 0.08 is 97.9% below this industry median. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Current Ratio compare to GNCA and ISCO?
Innoveren Scientific's Current Ratio of 0.08 can be compared against companies in the Biotechnology industry. The industry median Current Ratio is 3.89. Innoveren Scientific's value of 0.08 is 97.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innoveren Scientific's current Current Ratio of 0.08 is 97.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innoveren Scientific's current Current Ratio is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Current Ratio of 0.08. The current Current Ratio is 0.08 and 97.9% below the Biotechnology industry median of 3.89. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Current Ratio is 0.08 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price